Autoantibodies in Psoriatic Disease

Area of Science:

• Immunology
• Dermatology
• Rheumatology

Background:

• Psoriasis (Ps) affects millions, with psoriatic arthritis (PsA) impacting a quarter of patients.
• Psoriatic disease is an immune-mediated inflammatory condition with autoimmune and autoinflammatory characteristics.
• Inflammation in psoriatic disease is driven by innate immune cells, with a lymphocytic infiltrate.

Purpose of the Study:

• To review the literature on autoantibodies in psoriatic disease.
• To examine the clinical significance of identified autoantibodies.
• To assess associations with diagnosis, disease activity, and treatment.

Main Methods:

• Narrative review of existing scientific literature.
• Analysis of studies reporting autoantibody presence in psoriasis and psoriatic arthritis.
• Evaluation of data on autoantibody frequency and clinical correlations.

Main Results:

• Numerous autoantibodies have been identified in psoriatic disease patients.
• Many autoantibodies are elevated and linked to disease activity and treatment response.
• Associations with cardiovascular disease risk were also noted.

Conclusions:

• Autoantibodies suggest an autoimmune component in psoriatic disease.
• Further research is needed to clarify the clinical utility and pathogenic role of these autoantibodies.
• The findings highlight the complexity of psoriatic disease pathogenesis.